SCHEMBL25663109

SCHEMBL25663109

c1cnc2ccc(-c3ccc(N(c4ccc(-c5ccc6ncccc6n5)cc4)c4ccc(-c5ncnc6sc7ccccc7c56)cc4)cc3)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 6/20 0.39
▸ SYK P43405 4/20 0.33
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ APP P05067 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ RXFP1 Q9HBX9 1/20 0.30
▸ ADORA2A P29274 1/20 0.30
▸ PIK3CD O00329 1/20 0.30
▸ PIK3CA P42336 1/20 0.30
▸ PIK3CB P42338 1/20 0.30
▸ MTOR P42345 1/20 0.30
▸ PIK3CG P48736 1/20 0.30
▸ DHODH Q02127 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663098 0.89 RAB9A (0.39) TGFBR1KDM4EMAPTHPGDHTT
SCHEMBL25663108 0.89 NPC1 (0.40) KDM4EMAPTHPGDHTTSMN1; SMN2
SCHEMBL25663112 0.86 ELANE (0.32) —
SCHEMBL25663102 0.86 NPC1 (0.44) SYKCYP3A4ALDH1A1ADORA2APIK3CD
SCHEMBL25663114 0.85 NPC1 (0.37) SYKPIK3CDPIK3CAPIK3CBMTOR
SCHEMBL25663111 0.84 MAP4K4 (0.35) CYP3A4
SCHEMBL25663254 0.84 NPC1 (0.46) SYKPIK3CDPIK3CAPIK3CBMTOR
SCHEMBL25663110 0.84 NPC1 (0.33) CYP3A4
SCHEMBL25663258 0.84 PIK3CA (0.36) SYKADORA2APIK3CDPIK3CAPIK3CB
SCHEMBL25663193 0.83 TGFBR1 (0.38) TGFBR1SYKKDM4ESMN1; SMN2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 TGFBR1 1649/4885SYK 3826/4885KDM4E 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback